Condition: Metastatic Breast Cancer · Metastatic Gastrointestinal Carcinoma · HER2-positive Breast Cancer · Sponsor: Pravin T.P Kaumaya
This phase I trial studies the side effects and best dose of vaccine therapy in treating patients with metastatic solid tumors. Vaccines made from antibodies and peptides combined with tumor cells may help the body build an effective immune response to kill tumor cells.
This description comes directly from the study's public registry record.
Xin Bryan, RN · 317-274-5495 · zhongx@iu.edu
Always discuss trial participation with your own doctor first.
| Indiana University Melvin & Bren Simon Comprehensive Cancer Center | Indianpolis, Indiana, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06414733